Corient Private Wealth LLC Sells 67,466 Shares of Globe Life Inc. $GL

Corient Private Wealth LLC lessened its stake in shares of Globe Life Inc. (NYSE:GL) by 21.8% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 242,235 shares of the company’s stock after selling 67,466 shares during the period. Corient Private Wealth LLC owned about 0.30% of Globe Life worth $30,107,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Cresset Asset Management LLC purchased a new stake in Globe Life in the first quarter worth $253,000. Royal Bank of Canada grew its stake in shares of Globe Life by 14.4% during the 1st quarter. Royal Bank of Canada now owns 175,722 shares of the company’s stock worth $23,147,000 after acquiring an additional 22,143 shares during the period. Ieq Capital LLC increased its holdings in Globe Life by 63.8% in the 1st quarter. Ieq Capital LLC now owns 60,480 shares of the company’s stock worth $7,966,000 after acquiring an additional 23,553 shares during the last quarter. Inspire Investing LLC purchased a new stake in Globe Life in the 1st quarter worth about $797,000. Finally, American Century Companies Inc. raised its stake in Globe Life by 41.9% in the 1st quarter. American Century Companies Inc. now owns 205,421 shares of the company’s stock valued at $27,058,000 after acquiring an additional 60,606 shares during the period. Institutional investors own 81.61% of the company’s stock.

Globe Life Price Performance

Shares of NYSE:GL opened at $140.72 on Wednesday. The company has a 50 day moving average of $134.07 and a 200 day moving average of $132.89. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.41. The stock has a market cap of $11.20 billion, a P/E ratio of 10.20 and a beta of 0.48. Globe Life Inc. has a 12 month low of $103.88 and a 12 month high of $147.83.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, October 22nd. The company reported $4.81 EPS for the quarter, beating analysts’ consensus estimates of $4.54 by $0.27. The firm had revenue of $1.51 billion during the quarter, compared to analyst estimates of $1.52 billion. Globe Life had a net margin of 19.36% and a return on equity of 21.81%. During the same period in the previous year, the business earned $3.44 EPS. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS and its FY 2025 guidance at 14.400-14.600 EPS. As a group, sell-side analysts forecast that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Globe Life Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Monday, January 5th will be issued a $0.27 dividend. The ex-dividend date of this dividend is Monday, January 5th. This represents a $1.08 annualized dividend and a dividend yield of 0.8%. Globe Life’s dividend payout ratio (DPR) is presently 7.83%.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on GL shares. Morgan Stanley reiterated an “overweight” rating and set a $176.00 target price on shares of Globe Life in a research report on Monday. Truist Financial upped their price target on shares of Globe Life from $150.00 to $158.00 and gave the company a “buy” rating in a research note on Friday, October 24th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Globe Life in a research note on Monday. Wells Fargo & Company lowered their target price on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a report on Friday, October 24th. Finally, Piper Sandler restated an “overweight” rating and set a $167.00 target price on shares of Globe Life in a research report on Friday, November 21st. Nine analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $164.89.

Globe Life Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.